Genky DrugStores Co., Ltd. (TYO:9267)
4,485.00
-125.00 (-2.71%)
At close: Jan 23, 2026
Genky DrugStores Balance Sheet
Financials in millions JPY. Fiscal year is July - June.
Millions JPY. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 20, 2025 | Jun '25 Jun 20, 2025 | Jun '24 Jun 20, 2024 | Jun '23 Jun 20, 2023 | Jun '22 Jun 20, 2022 | Jun '21 Jun 20, 2021 | 2016 - 2020 |
Cash & Equivalents | 11,228 | 6,221 | 5,896 | 5,329 | 5,438 | 7,913 | Upgrade |
Cash & Short-Term Investments | 11,228 | 6,221 | 5,896 | 5,329 | 5,438 | 7,913 | Upgrade |
Cash Growth | 28.54% | 5.51% | 10.64% | -2.00% | -31.28% | 19.53% | Upgrade |
Accounts Receivable | 5,946 | 4,837 | 4,685 | 3,925 | 2,799 | 2,601 | Upgrade |
Other Receivables | - | 2,575 | 2,406 | 2,259 | 2,014 | 1,816 | Upgrade |
Receivables | 5,946 | 7,412 | 7,091 | 6,184 | 4,813 | 4,417 | Upgrade |
Inventory | 26,452 | 27,071 | 24,028 | 22,490 | 20,911 | 19,389 | Upgrade |
Other Current Assets | 3,245 | 506 | 319 | 410 | 352 | 421 | Upgrade |
Total Current Assets | 46,871 | 41,210 | 37,334 | 34,413 | 31,514 | 32,140 | Upgrade |
Property, Plant & Equipment | 81,583 | 79,203 | 69,936 | 65,104 | 59,260 | 52,527 | Upgrade |
Long-Term Investments | 6,601 | 3,857 | 3,760 | 3,637 | 3,680 | 3,569 | Upgrade |
Other Intangible Assets | 287 | 307 | 378 | 363 | 374 | 394 | Upgrade |
Long-Term Deferred Tax Assets | - | 2,120 | 2,039 | 1,840 | 1,698 | 1,578 | Upgrade |
Other Long-Term Assets | 1 | 2 | 2 | 1 | 1 | 1 | Upgrade |
Total Assets | 135,343 | 127,326 | 113,939 | 105,912 | 97,118 | 90,795 | Upgrade |
Accounts Payable | 33,368 | 26,732 | 24,188 | 22,192 | 20,564 | 19,616 | Upgrade |
Accrued Expenses | 474 | 121 | 133 | 136 | 105 | 128 | Upgrade |
Short-Term Debt | 558 | - | - | - | - | - | Upgrade |
Current Portion of Long-Term Debt | 8,618 | 8,412 | 8,088 | 11,242 | 10,180 | 6,816 | Upgrade |
Current Portion of Leases | - | 6 | 7 | 19 | 17 | 30 | Upgrade |
Current Income Taxes Payable | 1,048 | 7,132 | 6,939 | 5,467 | 5,594 | 6,330 | Upgrade |
Other Current Liabilities | 5,795 | 1,409 | 1,491 | 1,060 | 1,187 | 1,721 | Upgrade |
Total Current Liabilities | 49,861 | 43,812 | 40,846 | 40,116 | 37,647 | 34,641 | Upgrade |
Long-Term Debt | 25,921 | 25,817 | 22,408 | 20,946 | 20,754 | 21,684 | Upgrade |
Long-Term Leases | - | 139 | 145 | 147 | 8 | 25 | Upgrade |
Other Long-Term Liabilities | 4,262 | 4,131 | 3,861 | 4,023 | 2,477 | 2,281 | Upgrade |
Total Liabilities | 80,044 | 73,899 | 67,260 | 65,232 | 60,886 | 58,631 | Upgrade |
Common Stock | 1,044 | 1,035 | 1,024 | 1,010 | 1,008 | 1,000 | Upgrade |
Additional Paid-In Capital | 6,460 | 6,451 | 6,440 | 6,426 | 6,424 | 6,415 | Upgrade |
Retained Earnings | 48,373 | 46,534 | 39,862 | 33,917 | 29,531 | 25,479 | Upgrade |
Treasury Stock | -790 | -790 | -790 | -789 | -789 | -789 | Upgrade |
Comprehensive Income & Other | 212 | 197 | 143 | 116 | 58 | 59 | Upgrade |
Shareholders' Equity | 55,299 | 53,427 | 46,679 | 40,680 | 36,232 | 32,164 | Upgrade |
Total Liabilities & Equity | 135,343 | 127,326 | 113,939 | 105,912 | 97,118 | 90,795 | Upgrade |
Total Debt | 35,097 | 34,374 | 30,648 | 32,354 | 30,959 | 28,555 | Upgrade |
Net Cash (Debt) | -23,869 | -28,153 | -24,752 | -27,025 | -25,521 | -20,642 | Upgrade |
Net Cash Per Share | -783.36 | -924.42 | -813.77 | -889.27 | -839.63 | -679.35 | Upgrade |
Filing Date Shares Outstanding | 30.4 | 30.4 | 30.38 | 30.37 | 30.37 | 30.35 | Upgrade |
Total Common Shares Outstanding | 30.4 | 30.4 | 30.38 | 30.37 | 30.37 | 30.35 | Upgrade |
Working Capital | -2,990 | -2,602 | -3,512 | -5,703 | -6,133 | -2,501 | Upgrade |
Book Value Per Share | 1818.80 | 1757.70 | 1536.31 | 1339.57 | 1193.22 | 1059.62 | Upgrade |
Tangible Book Value | 55,012 | 53,120 | 46,301 | 40,317 | 35,858 | 31,770 | Upgrade |
Tangible Book Value Per Share | 1809.36 | 1747.60 | 1523.87 | 1327.62 | 1180.90 | 1046.64 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.